X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $306.03 million. The enterprise value is $261.19 million.
Important Dates
The next estimated earnings date is Tuesday, March 24, 2026, before market open.
| Earnings Date | Mar 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 87.44 million shares outstanding. The number of shares has increased by 141.76% in one year.
| Current Share Class | 87.44M |
| Shares Outstanding | 87.44M |
| Shares Change (YoY) | +141.76% |
| Shares Change (QoQ) | +483.74% |
| Owned by Insiders (%) | 0.27% |
| Owned by Institutions (%) | 63.91% |
| Float | 61.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.01 |
| Forward PS | 25.40 |
| PB Ratio | 1.43 |
| P/TBV Ratio | 8.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.65, with a Debt / Equity ratio of 1.26.
| Current Ratio | 5.65 |
| Quick Ratio | 5.27 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.20 |
Financial Efficiency
Return on equity (ROE) is -156.87% and return on invested capital (ROIC) is -511.91%.
| Return on Equity (ROE) | -156.87% |
| Return on Assets (ROA) | -33.54% |
| Return on Invested Capital (ROIC) | -511.91% |
| Return on Capital Employed (ROCE) | -65.48% |
| Weighted Average Cost of Capital (WACC) | 7.27% |
| Revenue Per Employee | $237,615 |
| Profits Per Employee | -$665,000 |
| Employee Count | 143 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, XFOR has paid $299,000 in taxes.
| Income Tax | 299,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.61% in the last 52 weeks. The beta is 0.46, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -67.61% |
| 50-Day Moving Average | 3.70 |
| 200-Day Moving Average | 3.20 |
| Relative Strength Index (RSI) | 51.19 |
| Average Volume (20 Days) | 597,635 |
Short Selling Information
The latest short interest is 3.38 million, so 3.86% of the outstanding shares have been sold short.
| Short Interest | 3.38M |
| Short Previous Month | 3.12M |
| Short % of Shares Out | 3.86% |
| Short % of Float | 5.53% |
| Short Ratio (days to cover) | 8.70 |
Income Statement
In the last 12 months, XFOR had revenue of $33.98 million and -$95.10 million in losses. Loss per share was -$5.90.
| Revenue | 33.98M |
| Gross Profit | 28.28M |
| Operating Income | -91.70M |
| Pretax Income | -94.80M |
| Net Income | -95.10M |
| EBITDA | -90.37M |
| EBIT | -91.70M |
| Loss Per Share | -$5.90 |
Full Income StatementBalance Sheet
The company has $122.19 million in cash and $77.36 million in debt, with a net cash position of $44.84 million or $0.51 per share.
| Cash & Cash Equivalents | 122.19M |
| Total Debt | 77.36M |
| Net Cash | 44.84M |
| Net Cash Per Share | $0.51 |
| Equity (Book Value) | 61.62M |
| Book Value Per Share | 2.45 |
| Working Capital | 109.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$103.09 million and capital expenditures -$41,000, giving a free cash flow of -$103.13 million.
| Operating Cash Flow | -103.09M |
| Capital Expenditures | -41,000 |
| Free Cash Flow | -103.13M |
| FCF Per Share | -$1.18 |
Full Cash Flow StatementMargins
Gross margin is 83.24%, with operating and profit margins of -269.87% and -279.86%.
| Gross Margin | 83.24% |
| Operating Margin | -269.87% |
| Pretax Margin | -278.98% |
| Profit Margin | -279.86% |
| EBITDA Margin | -265.96% |
| EBIT Margin | -269.87% |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -141.76% |
| Shareholder Yield | -141.76% |
| Earnings Yield | -31.07% |
| FCF Yield | -33.70% |
Analyst Forecast
The average price target for XFOR is $28.50, which is 714.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.50 |
| Price Target Difference | 714.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 147.60% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 28, 2025. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
XFOR has an Altman Z-Score of -5.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.38 |
| Piotroski F-Score | 3 |
